Anteris Technologies Global (NASDAQ:AVR) Posts Earnings Results, Misses Expectations By $0.01 EPS

Anteris Technologies Global (NASDAQ:AVR) posted its quarterly earnings results on Tuesday. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01), FiscalAI reports. The company had revenue of $0.49 million during the quarter, compared to analysts’ expectations of $0.77 million. Anteris Technologies Global had a negative return on equity of 1,053.55% and a negative net margin of 5,148.78%.During the same period last year, the company earned ($0.61) earnings per share.

Anteris Technologies Global Stock Performance

AVR stock traded up $0.50 during midday trading on Thursday, hitting $7.03. 338,632 shares of the company traded hands, compared to its average volume of 1,087,398. The business has a 50 day simple moving average of $5.92 and a 200-day simple moving average of $5.33. The stock has a market capitalization of $683.43 million, a price-to-earnings ratio of -3.14 and a beta of 1.32. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.01. Anteris Technologies Global has a twelve month low of $2.85 and a twelve month high of $7.10.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Lake Street Capital restated a “buy” rating and issued a $15.00 price objective on shares of Anteris Technologies Global in a report on Friday, January 23rd. Wells Fargo & Company assumed coverage on Anteris Technologies Global in a report on Wednesday, March 11th. They issued an “overweight” rating and a $16.00 price objective on the stock. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $15.00 price objective on shares of Anteris Technologies Global in a report on Friday, March 27th. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $15.33.

Institutional Investors Weigh In On Anteris Technologies Global

Several hedge funds and other institutional investors have recently modified their holdings of AVR. Russell Investments Group Ltd. grew its stake in shares of Anteris Technologies Global by 76.9% in the third quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock worth $29,000 after acquiring an additional 2,841 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Anteris Technologies Global in the first quarter worth $32,000. BNP Paribas Financial Markets grew its stake in shares of Anteris Technologies Global by 83.3% in the third quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock worth $43,000 after acquiring an additional 4,302 shares during the last quarter. Bank of America Corp DE grew its stake in shares of Anteris Technologies Global by 35.7% in the third quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after acquiring an additional 2,798 shares during the last quarter. Finally, Intech Investment Management LLC acquired a new stake in shares of Anteris Technologies Global in the fourth quarter worth $67,000.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.